Artículos de revistas
Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology.
Fecha
2015Registro en:
European Journal of Epidemiology,July 2015, vol. 30, n° 7, p. 569-576
Autor
Bennett, Derrick
Brayne, Carol
Feigin, Valery
Barker-Collo, Suzanne
Brinin, Michael
Davis, Daniel
Gallo, Valentina
Jetté, Nathalie
Karch, André
Kurtzke, John
Lavados, Pablo
Lagroscino, Giancarlo
Nagel, Gabriele
Preux, Pierre-Marie
Rothwell, Peter
Svenson, Lawrence
Institución
Resumen
Incidence and prevalence studies of neurological disorders play an important role in assessing the burden of disease and planning services. However, the assessment of disease estimates is hindered by problems in reporting for such studies. Despite a growth in published reports, existing guidelines relate to analytical rather than descriptive epidemiological studies. There are also no user-friendly tools (e.g., checklists) available for authors, editors and peer-reviewers to facilitate best practice in reporting of descriptive epidemiological studies for most neurological disorders. The Standards of Reporting of Neurological Disorders (STROND) is a guideline that consists of recommendations and a checklist to facilitate better reporting of published incidence and prevalence studies of neurological disorders. A review of previously developed guidance was used to produce a list of items required for incidence and prevalence studies in neurology. A three-round Delphi technique was used to identify the ‘basic minimum items’ important for reporting, as well as some additional ‘ideal reporting items’. An e-consultation process was then used in order to gauge opinion by external neuroepidemiological experts on the appropriateness of the items included in the checklist. Of 38 candidate items, 15 items and accompanying recommendations were developed along with a user-friendly checklist. The introduction and use of the STROND checklist should lead to more consistent, transparent and contextualised reporting of descriptive neuroepidemiological studies resulting in more applicable and comparable findings and ultimately support better healthcare decisions.